In June 2020, we formed a collaboration with the National Basketball Association (NBA) and the Players Association (NBPA) to develop a new saliva-based SARS-CoV-2 test (SalivaDirect) and to uncover key aspects of viral replication and transmission. Here is a selection of some of the news articles:

YSPH Magazine: YSPH-NBA Partnership Key to Success of New COVID-19 Saliva Test

The Athletic: How an assist from the NBA set up a small Yale lab for a COVID breakthrough

ESPN: Saliva-based coronavirus test funded by NBA, NBPA gets emergency authorization from FDA

Yale Daily News: Automation, pooling could come next for SalivaDirect as research team juggles authorization requests, media attention

Wall Street Journal: The FDA Authorizes a Cheap, Fast Saliva Test—and the NBA Is Involved

Yale News: Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization

USA Today: How NBA has expanded community testing for COVID-19 in team markets

Yale News: Yale and NBA partner to study efficacy of new COVID-19 test